Showing results (41-50 of 45) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Hematological Oncology|August 22, 2018
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study GroupSotirios G Papageorgiou, Christos K Kontos, Ioannis Kotsianidis, et al.Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.British Journal of Haematology|May 6, 2025
Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patientsAnthi Bouchla, Sotirios G Papageorgiou, Ioannis Kotsianidis, et al.Cancer Medicine|March 22, 2019
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registryPanagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, et al.Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.Pageof 5